Investors Buy Large Volume of Maravai LifeSciences Put Options (NASDAQ:MRVI)

Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) was the recipient of unusually large options trading activity on Wednesday. Investors acquired 1,002 put options on the company. This is an increase of 1,791% compared to the typical volume of 53 put options.

Analyst Ratings Changes

A number of equities analysts have weighed in on MRVI shares. Stifel Nicolaus decreased their price objective on shares of Maravai LifeSciences from $11.00 to $10.00 and set a “buy” rating for the company in a research report on Friday, February 23rd. Craig Hallum initiated coverage on shares of Maravai LifeSciences in a report on Wednesday, April 10th. They issued a “buy” rating and a $15.00 price objective for the company. Finally, Royal Bank of Canada raised their target price on shares of Maravai LifeSciences from $12.00 to $14.00 and gave the stock an “outperform” rating in a report on Friday, February 23rd. Three analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company’s stock. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $11.56.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently made changes to their positions in the stock. Bank of New York Mellon Corp grew its stake in shares of Maravai LifeSciences by 1.5% in the first quarter. Bank of New York Mellon Corp now owns 416,617 shares of the company’s stock valued at $14,694,000 after acquiring an additional 6,339 shares in the last quarter. Bank of Montreal Can increased its stake in Maravai LifeSciences by 13.6% during the 1st quarter. Bank of Montreal Can now owns 16,563 shares of the company’s stock valued at $591,000 after purchasing an additional 1,986 shares in the last quarter. MetLife Investment Management LLC bought a new stake in shares of Maravai LifeSciences in the 1st quarter worth $250,000. Dimensional Fund Advisors LP grew its position in Maravai LifeSciences by 534.6% during the first quarter. Dimensional Fund Advisors LP now owns 117,159 shares of the company’s stock valued at $4,133,000 after buying an additional 98,698 shares during the period. Finally, Sei Investments Co. lifted its holdings in Maravai LifeSciences by 7.5% during the first quarter. Sei Investments Co. now owns 159,229 shares of the company’s stock valued at $5,554,000 after purchasing an additional 11,079 shares during the last quarter. Institutional investors and hedge funds own 50.25% of the company’s stock.

Maravai LifeSciences Stock Performance

NASDAQ MRVI opened at $7.73 on Thursday. The company has a debt-to-equity ratio of 0.70, a current ratio of 8.00 and a quick ratio of 7.41. The company’s fifty day moving average is $7.48 and its two-hundred day moving average is $6.76. Maravai LifeSciences has a 52-week low of $4.52 and a 52-week high of $16.62. The firm has a market capitalization of $1.94 billion, a price-to-earnings ratio of -8.59 and a beta of 0.01.

Maravai LifeSciences (NASDAQ:MRVI) last announced its earnings results on Thursday, February 22nd. The company reported ($0.05) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.04) by ($0.01). The company had revenue of $74.14 million during the quarter, compared to the consensus estimate of $62.99 million. Maravai LifeSciences had a negative return on equity of 1.31% and a negative net margin of 41.19%. Equities research analysts forecast that Maravai LifeSciences will post -0.15 EPS for the current year.

Maravai LifeSciences Company Profile

Maravai LifeSciences Holdings, Inc, a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases worldwide. The company's products address the key phases of biopharmaceutical development and include nucleic acids for diagnostic and therapeutic applications, antibody-based products to detect impurities during the production of biopharmaceutical products, and products to detect the expression of proteins in tissues of various species.